Home > Healthcare > Drug Device Combination > Therapeutic Systems > Flowable Hemostats Market

Flowable Hemostats Market Share

Report ID: GMI9238
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Flowable Hemostats Market Share

The market is characterized by intense competition among key players striving to meet the growing demand for hemostatic agents. The competitive landscape is shaped by factors such as technological innovation, regulatory compliance, market penetration strategies, and customer preferences, driving companies to continuously adapt and innovate to maintain their market shares.

Flowable Hemostats Market Companies

Prominent players operating in the flowable hemostats industry include:

3D Matrix Medical Technology
Aegis Lifesciences Private Limited
Baxter International Inc.
CR Bard Inc. (Becton, Dickinson, and Company)
Ethicon, Inc. (Johnson & Johnson)
Ferrosan Medical Devices A/S
Integra LifeSciences Corporation
Medcura Inc.
Pfizer, Inc.
Teleflex Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Flowable hemostats industry size recorded USD 723.8 million in 2023 and will exhibit a 5.7% CAGR between 2024 and 2032 due to increasing surgical procedures, the rising prevalence of chronic diseases and traumatic injuries and technological advancements.

The orthopedic surgery segment registered 18.6% flowable hemostats industry share in 2023, driven by rising prevalence of orthopedic conditions, advancements in surgical techniques and the development of specialized hemostatic products.

North America flowable hemostats industry will record 5.4% CAGR up to 2032, owing to advanced healthcare infrastructure, high prevalence rates of chronic diseases requiring surgical interventions, and significant investments in research and development.

Major players operating in the flowable hemostats industry are 3D Matrix Medical Technology, Aegis Lifesciences Private Limited, Baxter International Inc., CR Bard Inc. (Becton, Dickinson, and Company), Ethicon, Inc. (Johnson & Johnson), Ferrosan Medical Devices A/S, Pfizer, Inc., and Teleflex Incorporated are among others.